Page 5 - Creative Biolabs News Today

Creative Biolabs, possessing industry-leading technology platforms and professional experience in protein discovery, provides full-set solutions for research involving membrane proteins, one of the most critical targets for therapeutics and diagnostics discovery.

Creative Biolabs, a world-leading diversified antibody-based CRO company, updates its single-domain antibody service line-up targeting immune molecules from llamas against COVID-19 variants.

/PRNewswire/ -- A humanized mouse model is an organism that has been genetically engineered to study immune responses to drugs or identify potential disease...

Fragment-Based Drug Discovery Market Research Insight 2022| Industry Development – Growth Opportunities in Future, Revenue Forecast Up to 2030

Fragment-Based Drug Discovery Market Research Insight 2022| Industry Development – Growth Opportunities in Future, Revenue Forecast Up to 2030

Creative Biolabs, Inc., a leading service provider for early drug discovery and development, has launched an advanced platform for membrane protein production and anti-membrane protein antibody discovery, Magic™.

Creative Biolab has announced this year's participation in international conferences and updates in its product catalog of antibodies.

Creative Biolabs will attend PEGS Boston Summit 2022 in May as sponsor and exhibitor, and sincerely invite all guests to visit booth #1124.

60% of Global Population Vaccinated against COVID-19

60% of Global Population Vaccinated against COVID-19